Cefovecin is a long-acting injectable third-generation cephalosporin antibiotic used in dogs for specific susceptible bacterial infections. The best-known veterinary brand is Convenia. Its defining feature is duration: one subcutaneous injection can maintain therapeutic concentrations for days, which can be useful when giving oral antibiotics is difficult. That convenience is also its main limitation—once injected, the drug cannot simply be removed if the dog has an adverse reaction or if culture results later show that another antibiotic would have been better.
Dog Medication Math Calculator
Enter your dog’s current body weight, then use only the dose already provided by your veterinarian or pharmacy label. The calculator converts lb/kg and can work out mg and liquid mL. It does not choose or recommend a dose.
Dose information from your veterinarian
Optional liquid conversion
Cefovecin should therefore be chosen for a clear reason, not simply because an injection sounds easier than tablets. FDA-approved canine use is focused on susceptible skin and soft-tissue infections. Broader extra-label use may occur, but antimicrobial stewardship, culture results and the dog’s clinical condition should guide whether a long-acting third-generation cephalosporin is appropriate.
How cefovecin works
Cefovecin is a beta-lactam antibiotic in the cephalosporin family. It inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins. Susceptible bacteria cannot maintain a normal cell wall and are damaged as they grow and divide.
Like other beta-lactams, cefovecin works best when the infecting organism is actually susceptible. The long duration does not compensate for choosing the wrong drug.
Why the injection lasts so long
Cefovecin is highly protein bound and has a prolonged elimination half-life in dogs and cats. That creates sustained drug exposure after one injection.
FDA approval data for Convenia describe therapeutic concentrations after a single canine injection for several days, with the exact period depending on the target organism. A second injection may be considered in selected dogs when clinical response is incomplete, but the decision should reflect progress, susceptibility and host-defense factors.
FDA-approved use in dogs
Convenia is approved in dogs for certain skin infections caused by susceptible bacteria, including wounds and abscesses. The product label and current FDA documentation define the approved organisms and treatment conditions.
It should not be assumed that a drug approved for skin infection is automatically a good choice for pneumonia, urinary infection, dental disease or every abscess. Tissue site and bacterial susceptibility matter.
Why culture is especially valuable with a long-acting injection
If a dog receives an oral antibiotic and culture later shows resistance, the prescription can usually be changed quickly. Cefovecin remains in the body after injection, so an ineffective or unnecessary choice cannot be “taken back.”
Culture and susceptibility testing are particularly useful in recurrent infection, prior antibiotic exposure, deep pyoderma, unusual organisms or treatment failure.
Third-generation cephalosporins and stewardship
Third-generation cephalosporins are important antimicrobial drugs. Merck Veterinary Manual emphasizes that their spectrum should be confirmed with bacteriologic culture and susceptibility testing rather than assumed to be broadly effective against every gram-negative or resistant organism.
Using a long-acting broad-spectrum antibiotic for a problem that could be treated with a narrower first-line agent can increase selection pressure without improving the dog’s outcome.
Cefovecin does not cover everything
Cefovecin should not be relied on for Enterococcus, methicillin-resistant Staphylococcus, Pseudomonas and several other problematic organisms. Resistance patterns also vary by region and prior antibiotic exposure.
A dog that fails to improve after an injection needs reassessment. Repeating the same drug without new information can extend an ineffective course.
Skin infections need a cause addressed
Bacterial pyoderma often develops because something else has damaged the skin barrier. Allergy, endocrine disease, parasites, moisture, skin folds and trauma can all contribute.
An antibiotic may clear the bacterial component while the underlying problem remains. Repeated injections without addressing the cause can create a cycle of relapse and antimicrobial exposure.
Abscesses and wounds
Some abscesses need drainage, clipping, cleaning or removal of foreign material. Antibiotics alone cannot always sterilize a closed pocket of pus or repair devitalized tissue.
If swelling enlarges, pain increases, fever develops or drainage persists after treatment, the dog should be re-examined.
Convenience can be clinically useful
Some dogs are nearly impossible to medicate orally, and missed doses can make an otherwise good antibiotic course fail. A long-acting injection may therefore improve adherence in the right case.
The best reason to use cefovecin is not owner convenience alone. The infection still needs to be one for which cefovecin is medically appropriate.
Convenia dosage by weight: current U.S. label
Current U.S. Convenia prescribing information uses a single subcutaneous dose of 8 mg/kg (3.6 mg/lb), equivalent to 0.045 mL/lb after reconstitution to 80 mg/mL. It is a clinic-administered injection, not an owner-calculated home medication.
| Dog weight | Label volume |
|---|---|
| 5 lb | 0.23 mL |
| 10 lb | 0.45 mL |
| 20 lb | 0.90 mL |
| 40 lb | 1.80 mL |
| 80 lb | 3.60 mL |
See the current Zoetis Convenia prescribing information. The label also notes that cefovecin can persist in the body for a prolonged period, which is one reason culture and careful case selection matter before an injection is given.
Possible side effects
Reported adverse effects can include vomiting, diarrhea, reduced appetite, lethargy and injection-site reactions. Most dogs tolerate the drug, but individual reactions occur.
Because exposure persists for days, contact the veterinarian if significant symptoms develop after injection rather than waiting for the drug to “wear off.”
Allergic reactions
Cephalosporins can cause hypersensitivity reactions. Facial swelling, hives, breathing difficulty, collapse or rapidly developing weakness after injection requires urgent veterinary care.
Tell the veterinarian if the dog has previously had a serious reaction to a penicillin or cephalosporin. Cross-reactivity is not universal, but allergy history matters.
Kidney disease
Cephalosporins are commonly eliminated through the kidneys to varying degrees. Renal disease can alter drug exposure, and long persistence makes this more relevant with cefovecin than with a short-acting drug that can simply be stopped.
The veterinarian may review kidney values before using cefovecin in older or medically complex dogs.
Liver disease and other chronic illness
A dog with liver disease, severe systemic illness or multiple medications deserves individualized assessment. The infection itself may alter appetite, hydration and laboratory results.
Baseline information helps separate disease progression from a possible medication effect if the dog becomes unwell after treatment.
What if the dog is already taking another antibiotic?
Do not add cefovecin simply because the first antibiotic has not worked after a day or two. Some infections need time to respond, and overlapping antibiotics can increase adverse effects and make culture interpretation more difficult.
If treatment is failing, culture, source control and diagnosis should be reviewed before stacking additional drugs.
Cefovecin and NSAIDs
There is no universal prohibition against using cefovecin with an NSAID, but dehydrated or systemically ill dogs may already be vulnerable to kidney injury. Every medication should be considered in the context of hydration and renal function.
Tell the veterinarian about carprofen, meloxicam, firocoxib, deracoxib and other pain medicines before treatment.
Why probiotics do not prevent every antibiotic problem
Some owners use probiotics during antibiotic therapy. They may be reasonable in selected dogs, but they do not prevent allergic reactions, resistance, renal issues or every case of diarrhea.
Persistent diarrhea, blood in stool or repeated vomiting should be assessed rather than covered with supplements while waiting.
What if the first injection seems to work only partly?
FDA labeling allows a second canine injection in selected cases when response is incomplete, but the decision should consider clinical progress, organism susceptibility and the dog’s defenses.
A partial response can also mean the infection is deeper than expected, the bacterial species is resistant, a foreign body remains, or the underlying skin disease is uncontrolled. Reassessment is better than automatically repeating the shot.
What if a dog receives too much?
Because cefovecin is administered by a veterinary professional, home dosing errors are less common than with tablets. If an incorrect amount is suspected, contact the clinic immediately so the actual administered dose and dog’s condition can be reviewed.
There is no practical way to withdraw an injected depot from the body once systemic absorption has begun.
Why a missed dose is different with cefovecin
There is usually no daily home dose to miss. The relevant scheduling issue is whether a planned recheck or second injection is delayed.
Do not assume a second injection is automatically necessary on a fixed date. The veterinarian should determine whether the infection has resolved or whether further treatment is justified.
Cefovecin versus cefpodoxime
Both are later-generation cephalosporins used in dogs. Cefpodoxime is oral and can be stopped or changed promptly. Cefovecin is injectable and long acting.
The choice involves organism, infection site, adherence, resistance concerns and the value of being able to adjust treatment rapidly.
Cefovecin versus cephalexin
Cephalexin is a first-generation oral cephalosporin commonly used for susceptible staphylococcal skin infections. When a narrower first-generation drug is appropriate and can be given reliably, it may be a better stewardship choice than a long-acting third-generation agent.
Broader generation does not automatically mean “stronger” or clinically superior.
Cefovecin versus amoxicillin-clavulanate
Amoxicillin-clavulanate covers a different spectrum and is commonly used for selected skin, soft-tissue, dental and other infections. It requires oral administration but can be adjusted quickly.
Culture and infection type should decide between them rather than convenience alone.
Urinary infections
Cefovecin may be used extra-label in some urinary cases, but a bacterial urinary tract infection should ideally be confirmed when recurrent, complicated or associated with kidney disease.
Urine culture is especially valuable because long-acting treatment cannot be modified easily if susceptibility results later show resistance.
Respiratory infections
A cough or nasal discharge does not automatically require cefovecin. Viral disease, airway inflammation, aspiration, fungal disease and noninfectious causes are common.
When bacterial pneumonia is suspected, culture from an appropriate respiratory sample and severity of illness can guide antibiotic choice more effectively than selecting a convenient injection.
Dental infections
Dental disease is primarily treated by addressing the diseased tooth, periodontal pocket or infected tissue. An antibiotic cannot correct a fractured tooth, retained root or severe periodontal disease.
Using cefovecin without dental source control may temporarily reduce inflammation while leaving the original problem intact.
Puppies and medically fragile dogs
Young, old, dehydrated or medically complex dogs may handle infections and medications differently. Product labeling and veterinary judgment should guide whether cefovecin is suitable.
Do not request a long-acting injection solely because a puppy is hard to pill if the infection or age falls outside the appropriate use.
Pregnancy and breeding
Reproductive safety should be assessed individually. Antibiotic need, infection severity and available alternatives all matter in pregnant or nursing dogs.
Never use another pet’s prior cefovecin treatment as a reason to assume it is appropriate during pregnancy.
Why follow-up still matters after a one-shot treatment
The convenience of one injection can create the impression that the problem is finished. Skin infections, abscesses and wounds still need clinical resolution.
Check whether redness, pain, swelling, discharge, odor and fever are improving. If the lesion is worsening, contact the veterinarian before the scheduled recheck.
Antibiotic-associated diarrhea
Changes in gut bacteria can cause loose stool during or after antibiotic treatment. Mild transient diarrhea can occur, but persistent or severe diarrhea deserves veterinary attention.
A long-acting injection means the drug remains present even if gastrointestinal signs begin, so supportive care may be needed while the antibiotic clears.
Resistance is not visible
A dog can appear to have “a strong infection” when the real issue is a resistant organism. Increasing antibiotic generation or duration without culture can compound the problem.
Recurrent pyoderma, previous methicillin-resistant Staphylococcus and repeated antibiotic courses are good reasons to prioritize bacterial culture.
Questions to ask before injection
Ask what infection is being treated, whether culture is indicated, why cefovecin is preferred over an oral narrower-spectrum option, what adverse effects to watch for and whether a second injection is expected or only considered if needed.
Also ask when the dog should be rechecked and what lack of improvement would trigger a change in plan.
Reliable references
FDA approval documents for Convenia (cefovecin sodium) describe approved canine use, long duration and criteria for a possible second injection. The Merck Veterinary Manual cephalosporin review discusses cefovecin’s class, spectrum and stewardship context.
What to watch during the days after injection
Because cefovecin remains active for an extended period, owners should keep observing appetite, stool quality, energy, swelling, discharge and pain after leaving the clinic. Improvement should be progressive. A dog that becomes more lethargic, vomits repeatedly or develops worsening local infection needs reassessment even though no daily tablets are being given.
The lack of a home dosing schedule should never be mistaken for a lack of follow-up responsibility.
Bottom line
Cefovecin is a useful long-acting injectable antibiotic when a susceptible infection and the dog’s circumstances make prolonged exposure appropriate. Its convenience is not a substitute for culture, source control or stewardship.
Because the drug cannot be quickly withdrawn after injection, the decision should be deliberate. Monitor the infection, report significant adverse effects and do not assume a second injection is automatically required.
DogMedsHub provides source-backed canine medication guidance and does not diagnose, prescribe or replace veterinary care.
Why long-acting exposure can be a disadvantage
The feature that makes cefovecin convenient also removes flexibility. If a dog develops diarrhea, an allergic reaction or culture later shows resistance, the injection cannot be discontinued in the same way an oral antibiotic can. Supportive care may be needed while the drug remains in the body.
This is why the initial decision deserves more thought than “one shot is easier.” Convenience is valuable only when the antibiotic is appropriate for the infection.
When oral medication is difficult but still preferable
Some dogs can be managed with flavored tablets, compounded liquids or training that makes oral medication practical. If a narrower-spectrum oral drug is the better stewardship choice, difficulty giving pills is a problem to solve rather than an automatic reason to choose cefovecin.
Ask the clinic to demonstrate pill administration or discuss formulations before assuming injections are the only realistic option.
Why abscess drainage matters
Antibiotics penetrate poorly into some closed pockets of pus. A bite wound or abscess may need opening, drainage, flushing or removal of devitalized tissue. Without source control, even a susceptible antibiotic can appear to fail.
Increasing swelling, pain or fever after injection should prompt re-examination rather than waiting for the next scheduled dose.
What recurrent pyoderma should trigger
Repeated skin infections are often a sign of allergy, endocrine disease, ectoparasites or resistant staphylococci. A long-acting antibiotic can suppress each flare without solving the reason it keeps returning.
When infections recur, bacterial culture and investigation of the underlying skin disease are better long-term strategies than repeating cefovecin automatically.
Why a second injection is a clinical decision
FDA labeling allows a second injection in selected canine cases, but “allowed” is not the same as “required.” If the lesion is already healed, more antibiotic may add exposure without benefit. If the lesion is not improving, the reason may be resistance or poor source control rather than insufficient duration.
The recheck should answer whether more cefovecin is justified, not simply repeat the original plan by habit.
